CVS Health Co. (NYSE:CVS) Shares Acquired by Soltis Investment Advisors LLC

Soltis Investment Advisors LLC boosted its stake in CVS Health Co. (NYSE:CVS) by 1.3% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 100,789 shares of the pharmacy operator’s stock after acquiring an additional 1,342 shares during the period. Soltis Investment Advisors LLC’s holdings in CVS Health were worth $6,338,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in the stock. ORG Partners LLC raised its position in shares of CVS Health by 11,840.0% during the 2nd quarter. ORG Partners LLC now owns 597 shares of the pharmacy operator’s stock valued at $35,000 after acquiring an additional 592 shares in the last quarter. Cornerstone Wealth Management LLC raised its holdings in shares of CVS Health by 7.6% during the second quarter. Cornerstone Wealth Management LLC now owns 17,174 shares of the pharmacy operator’s stock worth $1,014,000 after purchasing an additional 1,214 shares during the period. Westside Investment Management Inc. lifted its position in shares of CVS Health by 1.9% in the 2nd quarter. Westside Investment Management Inc. now owns 61,661 shares of the pharmacy operator’s stock worth $3,660,000 after buying an additional 1,163 shares during the last quarter. Hunter Perkins Capital Management LLC boosted its holdings in shares of CVS Health by 36.6% in the 2nd quarter. Hunter Perkins Capital Management LLC now owns 107,855 shares of the pharmacy operator’s stock valued at $6,370,000 after buying an additional 28,910 shares during the period. Finally, Lorne Steinberg Wealth Management Inc. grew its position in shares of CVS Health by 1.0% during the 2nd quarter. Lorne Steinberg Wealth Management Inc. now owns 98,677 shares of the pharmacy operator’s stock valued at $5,828,000 after buying an additional 935 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the stock. Truist Financial reissued a “buy” rating and issued a $67.00 target price (down previously from $76.00) on shares of CVS Health in a report on Wednesday, November 20th. Mizuho reduced their price objective on CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research report on Thursday, October 24th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $62.00 target price on shares of CVS Health in a research report on Tuesday, October 1st. Deutsche Bank Aktiengesellschaft upgraded CVS Health from a “hold” rating to a “buy” rating and set a $66.00 target price on the stock in a research note on Tuesday, December 3rd. Finally, Barclays dropped their price objective on shares of CVS Health from $75.00 to $71.00 and set an “overweight” rating on the stock in a report on Thursday, November 7th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and fourteen have given a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $70.50.

CVS Health Price Performance

NYSE:CVS opened at $55.15 on Wednesday. CVS Health Co. has a 52-week low of $52.71 and a 52-week high of $83.25. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. The firm has a market cap of $69.40 billion, a P/E ratio of 14.00, a PEG ratio of 0.95 and a beta of 0.54. The business’s 50-day moving average price is $59.21 and its 200 day moving average price is $58.78.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, topping analysts’ consensus estimates of $1.08 by $0.01. The business had revenue of $95.43 billion for the quarter, compared to the consensus estimate of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The business’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same period in the previous year, the firm earned $2.21 EPS. As a group, sell-side analysts predict that CVS Health Co. will post 5.32 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 4.82%. The ex-dividend date was Monday, October 21st. CVS Health’s dividend payout ratio is presently 67.51%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.